Atsushi Inanobe, Hiroyasu Furukawa, Eric Gouaux
Index: Neuron 47(1) , 71-84, (2005)
Full Text: HTML
Partial agonists produce submaximal activation of ligand-gated ion channels. To address the question of partial agonist action at the NR1 subunit of the NMDA receptor, we performed crystallographic and electrophysiological studies with 1-aminocyclopropane-1-carboxylic acid (ACPC), 1-aminocyclobutane-1-carboxylic acid (ACBC), and 1-aminocyclopentane-1-carboxylic acid (cycloleucine), three compounds with incrementally larger carbocyclic rings. Whereas ACPC and ACBC partially activate the NMDA receptor by 80% and 42%, respectively, their cocrystal structures of the NR1 ligand binding core show the same degree of domain closure as found in the complex with glycine, a full agonist, illustrating that the NR1 subunit provides a new paradigm for partial agonist action that is distinct from that of the evolutionarily related GluR2, AMPA-sensitive receptor. Cycloleucine behaves as an antagonist and stabilizes an open-cleft conformation. The NR1-cycloleucine complex forms a dimer that is similar to the GluR2 dimer, thereby suggesting a conserved mode of subunit-subunit interaction in AMPA and NMDA receptors.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
1-Aminocyclobutanecarboxylic acid
CAS:22264-50-2 |
C5H9NO2 |
|
[Change in the level of 1-aminochloropropane-1-carbonic acid...
2003-01-01 [Prikl. Biokhim. Mikrobiol. 39(4) , 461-4, (2003)] |
|
Glycine antagonist action of 1-aminocyclobutane-1-carboxylat...
1989-08-22 [Eur. J. Pharmacol. 167(2) , 291-4, (1989)] |
|
Ethylene biosynthesis: processing of a substrate analog supp...
1998-01-01 [Chem. Biol. 5(1) , 49-57, (1998)] |
|
Dietary N-3 fatty acids inhibit ischaemic and excitotoxic br...
1993-01-01 [Brain Res. Bull. 32(3) , 223-6, (1993)] |
|
1-aminocyclobutane[11C]carboxylic acid, a potential tumor-se...
1979-10-01 [J. Nucl. Med. 20(10) , 1055-61, (1979)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2026 ChemSrc All Rights Reserved
